Literature DB >> 28529589

Tetrandrine triggers an alternative autophagy in DU145 cells.

Wei Qiu1, Ai-Li Zhang2, Ye Tian1.   

Abstract

Tetrandrine (Tet), a potent lysosomal inhibitor, blocks autophagic flux and induces cancer cell death. Previously, the present authors identified the prostate cancer cell line DU145 to exhibit high sensitivity towards Tet in 11 cancer cell lines. In the present study, autophagy in Tet-treated DU145 cells was investigated. Similar to other cell lines, such as PC-3 and 786-O cells, Tet neutralized the acidity of lysosome and blocked autophagy in DU145 cells. However, Tet failed to induce microtubule-associated protein 1 light chain 3 (LC3) conversion in DU145 cells. By contrast, it was observed by transmission electron microscopy that Tet induced an accumulation of autophagosomes in the cytoplasm. These contrasting results indicated that Tet triggered an LC3-independent autophagy in DU145 cells. Alkalizing lysosome with chloroquine enhanced Tet-induced cell death. The results of the present study indicated that detection of autophagy in tumor cells may assist in selecting lysosome inhibitors for chemotherapy treatment in prostate cancer.

Entities:  

Keywords:  DU145 cell line; autophagosome; autophagy; prostate cancer; tetrandrine

Year:  2017        PMID: 28529589      PMCID: PMC5431440          DOI: 10.3892/ol.2017.5897

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  19 in total

1.  LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.

Authors:  Y Kabeya; N Mizushima; T Ueno; A Yamamoto; T Kirisako; T Noda; E Kominami; Y Ohsumi; T Yoshimori
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

2.  Tetrandrine inhibits proinflammatory cytokines, iNOS and COX-2 expression in human monocytic cells.

Authors:  Shu-Jing Wu; Lean-Teik Ng
Journal:  Biol Pharm Bull       Date:  2007-01       Impact factor: 2.233

3.  Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21.

Authors:  Liufeng Mei; Yicheng Chen; Zhimeng Wang; Jian Wang; Jiali Wan; Chunrong Yu; Xin Liu; Wenhua Li
Journal:  Br J Pharmacol       Date:  2015-03-17       Impact factor: 8.739

4.  Tetrandrine enhances the anticancer effects of arsenic trioxide in vitro.

Authors:  Youran Chen; Peichun Li; Shen Yang; Nannan Tong; Jie Zhang; Xiaoyan Zhao
Journal:  Int J Clin Pharmacol Ther       Date:  2014-05       Impact factor: 1.366

5.  Autophagy-related gene 7 (ATG7) and reactive oxygen species/extracellular signal-regulated kinase regulate tetrandrine-induced autophagy in human hepatocellular carcinoma.

Authors:  Ke Gong; Chao Chen; Yao Zhan; Yan Chen; Zebo Huang; Wenhua Li
Journal:  J Biol Chem       Date:  2012-08-27       Impact factor: 5.157

6.  Tetrandrine induces cell death in SAS human oral cancer cells through caspase activation-dependent apoptosis and LC3-I and LC3-II activation-dependent autophagy.

Authors:  An-Cheng Huang; Jin-Cherng Lien; Meng-Wei Lin; Jai-Sing Yang; Ping-Ping Wu; Shu-Jen Chang; Tung-Yuan Lai
Journal:  Int J Oncol       Date:  2013-05-21       Impact factor: 5.650

7.  Discovery of Atg5/Atg7-independent alternative macroautophagy.

Authors:  Yuya Nishida; Satoko Arakawa; Kenji Fujitani; Hirofumi Yamaguchi; Takeshi Mizuta; Toku Kanaseki; Masaaki Komatsu; Kinya Otsu; Yoshihide Tsujimoto; Shigeomi Shimizu
Journal:  Nature       Date:  2009-10-01       Impact factor: 49.962

Review 8.  Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes.

Authors:  Daniel J Klionsky; Hagai Abeliovich; Patrizia Agostinis; Devendra K Agrawal; Gjumrakch Aliev; David S Askew; Misuzu Baba; Eric H Baehrecke; Ben A Bahr; Andrea Ballabio; Bruce A Bamber; Diane C Bassham; Ettore Bergamini; Xiaoning Bi; Martine Biard-Piechaczyk; Janice S Blum; Dale E Bredesen; Jeffrey L Brodsky; John H Brumell; Ulf T Brunk; Wilfried Bursch; Nadine Camougrand; Eduardo Cebollero; Francesco Cecconi; Yingyu Chen; Lih-Shen Chin; Augustine Choi; Charleen T Chu; Jongkyeong Chung; Peter G H Clarke; Robert S B Clark; Steven G Clarke; Corinne Clavé; John L Cleveland; Patrice Codogno; María I Colombo; Ana Coto-Montes; James M Cregg; Ana Maria Cuervo; Jayanta Debnath; Francesca Demarchi; Patrick B Dennis; Phillip A Dennis; Vojo Deretic; Rodney J Devenish; Federica Di Sano; J Fred Dice; Marian Difiglia; Savithramma Dinesh-Kumar; Clark W Distelhorst; Mojgan Djavaheri-Mergny; Frank C Dorsey; Wulf Dröge; Michel Dron; William A Dunn; Michael Duszenko; N Tony Eissa; Zvulun Elazar; Audrey Esclatine; Eeva-Liisa Eskelinen; László Fésüs; Kim D Finley; José M Fuentes; Juan Fueyo; Kozo Fujisaki; Brigitte Galliot; Fen-Biao Gao; David A Gewirtz; Spencer B Gibson; Antje Gohla; Alfred L Goldberg; Ramon Gonzalez; Cristina González-Estévez; Sharon Gorski; Roberta A Gottlieb; Dieter Häussinger; You-Wen He; Kim Heidenreich; Joseph A Hill; Maria Høyer-Hansen; Xun Hu; Wei-Pang Huang; Akiko Iwasaki; Marja Jäättelä; William T Jackson; Xuejun Jiang; Shengkan Jin; Terje Johansen; Jae U Jung; Motoni Kadowaki; Chanhee Kang; Ameeta Kelekar; David H Kessel; Jan A K W Kiel; Hong Pyo Kim; Adi Kimchi; Timothy J Kinsella; Kirill Kiselyov; Katsuhiko Kitamoto; Erwin Knecht; Masaaki Komatsu; Eiki Kominami; Seiji Kondo; Attila L Kovács; Guido Kroemer; Chia-Yi Kuan; Rakesh Kumar; Mondira Kundu; Jacques Landry; Marianne Laporte; Weidong Le; Huan-Yao Lei; Michael J Lenardo; Beth Levine; Andrew Lieberman; Kah-Leong Lim; Fu-Cheng Lin; Willisa Liou; Leroy F Liu; Gabriel Lopez-Berestein; Carlos López-Otín; Bo Lu; Kay F Macleod; Walter Malorni; Wim Martinet; Ken Matsuoka; Josef Mautner; Alfred J Meijer; Alicia Meléndez; Paul Michels; Giovanni Miotto; Wilhelm P Mistiaen; Noboru Mizushima; Baharia Mograbi; Iryna Monastyrska; Michael N Moore; Paula I Moreira; Yuji Moriyasu; Tomasz Motyl; Christian Münz; Leon O Murphy; Naweed I Naqvi; Thomas P Neufeld; Ichizo Nishino; Ralph A Nixon; Takeshi Noda; Bernd Nürnberg; Michinaga Ogawa; Nancy L Oleinick; Laura J Olsen; Bulent Ozpolat; Shoshana Paglin; Glen E Palmer; Issidora Papassideri; Miles Parkes; David H Perlmutter; George Perry; Mauro Piacentini; Ronit Pinkas-Kramarski; Mark Prescott; Tassula Proikas-Cezanne; Nina Raben; Abdelhaq Rami; Fulvio Reggiori; Bärbel Rohrer; David C Rubinsztein; Kevin M Ryan; Junichi Sadoshima; Hiroshi Sakagami; Yasuyoshi Sakai; Marco Sandri; Chihiro Sasakawa; Miklós Sass; Claudio Schneider; Per O Seglen; Oleksandr Seleverstov; Jeffrey Settleman; John J Shacka; Irving M Shapiro; Andrei Sibirny; Elaine C M Silva-Zacarin; Hans-Uwe Simon; Cristiano Simone; Anne Simonsen; Mark A Smith; Katharina Spanel-Borowski; Vickram Srinivas; Meredith Steeves; Harald Stenmark; Per E Stromhaug; Carlos S Subauste; Seiichiro Sugimoto; David Sulzer; Toshihiko Suzuki; Michele S Swanson; Ira Tabas; Fumihiko Takeshita; Nicholas J Talbot; Zsolt Tallóczy; Keiji Tanaka; Kozo Tanaka; Isei Tanida; Graham S Taylor; J Paul Taylor; Alexei Terman; Gianluca Tettamanti; Craig B Thompson; Michael Thumm; Aviva M Tolkovsky; Sharon A Tooze; Ray Truant; Lesya V Tumanovska; Yasuo Uchiyama; Takashi Ueno; Néstor L Uzcátegui; Ida van der Klei; Eva C Vaquero; Tibor Vellai; Michael W Vogel; Hong-Gang Wang; Paul Webster; John W Wiley; Zhijun Xi; Gutian Xiao; Joachim Yahalom; Jin-Ming Yang; George Yap; Xiao-Ming Yin; Tamotsu Yoshimori; Li Yu; Zhenyu Yue; Michisuke Yuzaki; Olga Zabirnyk; Xiaoxiang Zheng; Xiongwei Zhu; Russell L Deter
Journal:  Autophagy       Date:  2007-11-21       Impact factor: 16.016

9.  Tetrandrine blocks autophagic flux and induces apoptosis via energetic impairment in cancer cells.

Authors:  W Qiu; M Su; F Xie; J Ai; Y Ren; J Zhang; R Guan; W He; Y Gong; Y Guo
Journal:  Cell Death Dis       Date:  2014-03-13       Impact factor: 8.469

10.  Sorafenib-induced defective autophagy promotes cell death by necroptosis.

Authors:  Pedram Kharaziha; Dimitris Chioureas; George Baltatzis; Pedro Fonseca; Patricia Rodriguez; Vladimir Gogvadze; Lena Lennartsson; Ann-Charlotte Björklund; Boris Zhivotovsky; Dan Grandér; Lars Egevad; Sten Nilsson; Theocharis Panaretakis
Journal:  Oncotarget       Date:  2015-11-10
View more
  3 in total

1.  Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression.

Authors:  Dan Liao; Wei Zhang; Pranav Gupta; Zi-Ning Lei; Jing-Quan Wang; Chao-Yun Cai; Albert A De Vera; Lei Zhang; Zhe-Sheng Chen; Dong-Hua Yang
Journal:  Molecules       Date:  2019-11-30       Impact factor: 4.411

Review 2.  The Secrets of Alternative Autophagy.

Authors:  Kaja Urbańska; Arkadiusz Orzechowski
Journal:  Cells       Date:  2021-11-19       Impact factor: 6.600

3.  Self-Nanoemulsifying Drug Delivery System of Tetrandrine for Improved Bioavailability: Physicochemical Characterization and Pharmacokinetic Study.

Authors:  Chunxia Liu; Li Lv; Wei Guo; Lan Mo; Yaoxing Huang; Guocheng Li; Xingzhen Huang
Journal:  Biomed Res Int       Date:  2018-09-27       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.